IBRX
Immunitybio Inc
9.30$
-1.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -71.5% | -0.2% | -3.3% | +0.7% | -6.8% | -7.5% | +1.3% | +1.8% | -2.2% | +13.3% | +100.6% | – | |
| – | -11.6% | -35.3% | +16.6% | -22.3% | +20.7% | +5.5% | +1.2% | -8.0% | -1.5% | -6.6% | +104.3% | – | |
| – | – | – | – | -287.4% | – | – | – | – | – | – | – | – | |
| – | +40.2% | -84.1% | -42.6% | +285.6% | -24.4% | -46.9% | -3.6% | -28.3% | +64.5% | +40.2% | +196.1% | – | |
| – | – | -1,683.9% | +44.5% | – | -84.9% | -58.0% | -490.9% | +1,023.5% | – | -172.6% | +339.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.7% | +147.6% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | +200.0% | – | -98.3% | -125.0% | – | |
| – | -15.6% | -94.9% | +1,356.2% | -89.5% | +586.2% | -100.9% | – | +0.4% | -68.4% | +307.9% | +19.8% | – | |
| – | -34.9% | -251.4% | – | – | – | -361.8% | – | -199.7% | – | +316.0% | -110.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.